Mizhuo's Top Picks in Healthcare for July

Seeking AlphaJul 4 01:34

Arcutis Biotherapeutics(ARQT.US) Director Sells US$93,141 in Common Stock

$Arcutis Biotherapeutics(ARQT.US)$ Director Welgus Howard G. sold 10,000 shares of common stock on Jul 1, 2024 at an average price of $9.3141 for a total value of $93,141.Source: Announcement What is

Futu NewsJul 3 07:53

Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals

New York, USA, July 02, 2024 (GLOBE NEWSWIRE) -- Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant

GlobeNewswireJul 3 01:00

AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer

Yahoo FinanceJun 27 00:57

Arcutis Biotherapeutics Insiders Sold US$619k Of Shares Suggesting Hesitancy

A number of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) insiders sold their shares in the last year, which may have raised concerns among investors. When evaluating insider transactions, knowing whe

Simply Wall StJun 21 18:27

Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Thursday.Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) fell sharply in today's pre-market trading

BenzingaJun 20 17:29